Literature DB >> 24977012

Meis1 regulates proliferation of non-small-cell lung cancer cells.

Weihao Li1, Kai Huang1, Haizhou Guo1, Guanghui Cui1.   

Abstract

As one of the most common cancers, lung cancer remains to be a major public health problem. Non-small-cell lung adenocarcinoma cancer exhibits higher resistance to chemotherapy than small cell lung cancer, which requires novel strategies. To further understand underlying mechanisms for non-small-cell lung adenocarcinoma cancer cell proliferation, we explored the role of Meis1 in non-small-cell lung adenocarcinoma cancer cells. The results show that Meis1 inhibits non-small-cell lung cancer (NSCLC) cell proliferation. Specific knockdown of Meis1 resulted in strengthened proliferative ability of non-small-cell lung adenocarcinoma cancer cells. Cell cycle analysis indicated that DNA synthesis was increased when Meis1 was down-regulated specifically. As well as histone H3 phosphorylation, which is indicative of mitosis. More importantly, forced Meis1 expression repressed the proliferation of non-small-cell lung adenocarcinoma cancer cell. These data demonstrated Meis1 limits the proliferation of non-small-cell lung adenocarcinoma cancer cell and could potentially represent a therapeutic strategy that may control non-small-cell lung adenocarcinoma cancer cell proliferation.

Entities:  

Keywords:  Meis1; cell cycle; non-small-cell lung cancer (NSCLC); proliferation

Year:  2014        PMID: 24977012      PMCID: PMC4073365          DOI: 10.3978/j.issn.2072-1439.2014.06.03

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  16 in total

Review 1.  Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis.

Authors:  Bob Argiropoulos; Eric Yung; R Keith Humphries
Journal:  Genes Dev       Date:  2007-11-15       Impact factor: 11.361

2.  The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32.

Authors:  N Spieker; P van Sluis; M Beitsma; K Boon; B D van Schaik; A H van Kampen; H Caron; R Versteeg
Journal:  Genomics       Date:  2001-01-15       Impact factor: 5.736

3.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

4.  Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells.

Authors:  Fatih Kocabas; Junke Zheng; Suwannee Thet; Neal G Copeland; Nancy A Jenkins; Ralph J DeBerardinis; Chengcheng Zhang; Hesham A Sadek
Journal:  Blood       Date:  2012-09-20       Impact factor: 22.113

5.  Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia.

Authors:  U Thorsteinsdottir; E Kroon; L Jerome; F Blasi; G Sauvageau
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

6.  Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.

Authors:  H Kawagoe; R K Humphries; A Blair; H J Sutherland; D E Hogge
Journal:  Leukemia       Date:  1999-05       Impact factor: 11.528

7.  The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche.

Authors:  Tugba Simsek; Fatih Kocabas; Junke Zheng; Ralph J Deberardinis; Ahmed I Mahmoud; Eric N Olson; Jay W Schneider; Cheng Cheng Zhang; Hesham A Sadek
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

8.  Meis1 regulates postnatal cardiomyocyte cell cycle arrest.

Authors:  Ahmed I Mahmoud; Fatih Kocabas; Shalini A Muralidhar; Wataru Kimura; Ahmed S Koura; Suwannee Thet; Enzo R Porrello; Hesham A Sadek
Journal:  Nature       Date:  2013-04-17       Impact factor: 49.962

9.  Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.

Authors:  Piu Wong; Masayuki Iwasaki; Tim C P Somervaille; Chi Wai Eric So; Chai Wai Eric So; Michael L Cleary
Journal:  Genes Dev       Date:  2007-10-17       Impact factor: 11.361

10.  Hematopoietic, angiogenic and eye defects in Meis1 mutant animals.

Authors:  Tomoyuki Hisa; Sally E Spence; Rivka A Rachel; Masami Fujita; Takuro Nakamura; Jerrold M Ward; Deborah E Devor-Henneman; Yuriko Saiki; Haruo Kutsuna; Lino Tessarollo; Nancy A Jenkins; Neal G Copeland
Journal:  EMBO J       Date:  2004-01-08       Impact factor: 11.598

View more
  14 in total

1.  MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.

Authors:  Raj R Bhanvadia; Calvin VanOpstall; Hannah Brechka; Nimrod S Barashi; Marc Gillard; Erin M McAuley; Juan Manuel Vasquez; Gladell Paner; Wen-Ching Chan; Jorge Andrade; Angelo M De Marzo; Misop Han; Russell Z Szmulewitz; Donald J Vander Griend
Journal:  Clin Cancer Res       Date:  2018-05-01       Impact factor: 12.531

2.  Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma.

Authors:  Zaiyan Wang; Xiaoning Li; Hao Chen; Li Han; Xiaobin Ji; Qiubo Wang; Li Wei; Yafang Miao; Jing Wang; Jianfeng Mao; Zeming Zhang
Journal:  Med Sci Monit       Date:  2021-05-12

3.  HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions.

Authors:  Hannah Brechka; Raj R Bhanvadia; Calvin VanOpstall; Donald J Vander Griend
Journal:  Genes Dis       Date:  2017-02-16

4.  Transcription Factor and lncRNA Regulatory Networks Identify Key Elements in Lung Adenocarcinoma.

Authors:  Dan Li; William Yang; Jialing Zhang; Jack Y Yang; Renchu Guan; Mary Qu Yang
Journal:  Genes (Basel)       Date:  2018-01-05       Impact factor: 4.096

5.  MEIS1 inhibits clear cell renal cell carcinoma cells proliferation and in vitro invasion or migration.

Authors:  Jie Zhu; Liang Cui; Axiang Xu; Xiaotao Yin; Fanglong Li; Jiangping Gao
Journal:  BMC Cancer       Date:  2017-03-07       Impact factor: 4.430

6.  MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans.

Authors:  Calvin VanOpstall; Srikanth Perike; Hannah Brechka; Marc Gillard; Sophia Lamperis; Baizhen Zhu; Ryan Brown; Raj Bhanvadia; Donald J Vander Griend
Journal:  Elife       Date:  2020-06-18       Impact factor: 8.140

7.  MEIS1 knockdown may promote differentiation of esophageal squamous carcinoma cell line KYSE-30.

Authors:  Reihaneh Alsadat Mahmoudian; Bahareh Bahadori; Abolfazl Rad; Mohammad Reza Abbaszadegan; Mohammad Mahdi Forghanifard
Journal:  Mol Genet Genomic Med       Date:  2019-05-14       Impact factor: 2.183

8.  MEIS-1 level in unresectable hepatocellular carcinoma can predict the post-treatment outcomes of radiofrequency ablation.

Authors:  Hui Xie; Haipeng Yu; Shengtao Tian; Xueling Yang; Ximing Wang; Huaming Wang; Zhi Guo
Journal:  Oncotarget       Date:  2018-01-11

9.  Myeloid ecotropic viral integration site 1 inhibits cell proliferation, invasion or migration in human gastric cancer.

Authors:  Fei Song; Hong Wang; Yingying Wang
Journal:  Oncotarget       Date:  2017-09-28

10.  Whole-Genome Methylation Study of Congenital Lung Malformations in Children.

Authors:  Sara Patrizi; Federica Pederiva; Adamo Pio d'Adamo
Journal:  Front Oncol       Date:  2021-06-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.